Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

NCT05409989 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.

NCT NCT05409989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
Lead sponsor
Microvention-Terumo, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 20, 2022
Completion date
May 31, 2030
Enrollment
154 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm